Ador Multiproducts Limited (ADORMUL.BO)
INR 31.12
(-7.05%)
INR 31.12
(-7.05%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 28.52 Million INR | -72.44% |
| 2022 | 103.5 Million INR | 55.52% |
| 2021 | 66.55 Million INR | -18.08% |
| 2020 | 81.23 Million INR | -26.49% |
| 2019 | 110.51 Million INR | 240.57% |
| 2018 | 32.45 Million INR | 33.44% |
| 2017 | 24.31 Million INR | -43.14% |
| 2016 | 42.76 Million INR | 12.68% |
| 2015 | 37.95 Million INR | 5.6% |
| 2014 | 35.94 Million INR | 10.75% |
| 2013 | 32.45 Million INR | 61.0% |
| 2012 | 20.15 Million INR | 22.08% |
| 2011 | 16.51 Million INR | -10.51% |
| 2010 | 18.45 Million INR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | -52.58 Million INR | -284.34% |
| 2024 Q2 | 20.25 Million INR | 138.57% |
| 2023 Q3 | - INR | -100.0% |
| 2023 FY | 28.52 Million INR | -72.44% |
| 2023 Q2 | 87.92 Million INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q4 | 28.52 Million INR | 0.0% |
| 2022 FY | 103.5 Million INR | 55.52% |
| 2022 Q4 | 103.5 Million INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 65 Million INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 FY | 66.55 Million INR | -18.08% |
| 2021 Q2 | 67.49 Million INR | 0.0% |
| 2021 Q4 | 66.55 Million INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2020 Q4 | 81.23 Million INR | 0.0% |
| 2020 Q2 | 100.33 Million INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 FY | 81.23 Million INR | -26.49% |
| 2020 Q3 | - INR | -100.0% |
| 2019 FY | 110.51 Million INR | 240.57% |
| 2019 Q4 | 110.51 Million INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q2 | 35.06 Million INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 Q4 | 25.88 Million INR | 0.0% |
| 2018 Q2 | 18.73 Million INR | 0.0% |
| 2018 FY | 32.45 Million INR | 33.44% |
| 2018 Q3 | - INR | -100.0% |
| 2017 Q2 | 47.76 Million INR | 0.0% |
| 2017 Q1 | - INR | -100.0% |
| 2017 Q3 | - INR | -100.0% |
| 2017 Q4 | 24.31 Million INR | 0.0% |
| 2017 FY | 24.31 Million INR | -43.14% |
| 2016 FY | 42.76 Million INR | 12.68% |
| 2016 Q4 | 45.8 Million INR | 0.0% |
| 2016 Q2 | 49.24 Million INR | 0.0% |
| 2016 Q3 | - INR | -100.0% |
| 2016 Q1 | - INR | -100.0% |
| 2015 Q2 | 38.96 Million INR | 0.0% |
| 2015 Q3 | - INR | -100.0% |
| 2015 Q4 | 37.95 Million INR | 0.0% |
| 2015 FY | 37.95 Million INR | 5.6% |
| 2015 Q1 | - INR | -100.0% |
| 2014 Q1 | - INR | -100.0% |
| 2014 FY | 35.94 Million INR | 10.75% |
| 2014 Q4 | 35.94 Million INR | 0.0% |
| 2014 Q3 | - INR | -100.0% |
| 2014 Q2 | 33.32 Million INR | 0.0% |
| 2013 Q4 | 32.45 Million INR | 0.0% |
| 2013 Q3 | - INR | -100.0% |
| 2013 Q2 | 31.08 Million INR | 0.0% |
| 2013 FY | 32.45 Million INR | 61.0% |
| 2013 Q1 | - INR | -100.0% |
| 2012 Q2 | 17.38 Million INR | 0.0% |
| 2012 Q4 | 20.15 Million INR | 0.0% |
| 2012 FY | 20.15 Million INR | 22.08% |
| 2011 Q4 | 16.51 Million INR | 0.0% |
| 2011 FY | 16.51 Million INR | -10.51% |
| 2010 FY | 18.45 Million INR | 0.0% |
| 2010 Q4 | 18.45 Million INR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Ambica Agarbathies Aroma & Industries Limited | 1.09 Billion INR | 97.406% |
| Bajaj Consumer Care Limited | 1.53 Billion INR | 98.135% |
| Colgate-Palmolive (India) Limited | 13.22 Billion INR | 99.784% |
| Cupid Limited | 186.52 Million INR | 84.706% |
| Dabur India Limited | 48.19 Billion INR | 99.941% |
| Emami Limited | 8.21 Billion INR | 99.653% |
| Gillette India Limited | 8.59 Billion INR | 99.668% |
| Godrej Consumer Products Limited | 58.97 Billion INR | 99.952% |
| Hindustan Unilever Limited | 270.76 Billion INR | 99.989% |
| Hipolin Limited | 48.57 Million INR | 41.268% |
| Honasa Consumer Limited | 5.36 Billion INR | 99.469% |
| JHS Svendgaard Laboratories Limited | 271.7 Million INR | 89.5% |
| Jyothy Labs Limited | 5.9 Billion INR | 99.517% |
| Kaya Limited | 5.22 Billion INR | 99.454% |
| Marico Limited | 32.52 Billion INR | 99.912% |
| N.K Industries Limited | 22.4 Billion INR | 99.873% |
| PAOS INDUSTRIES LIMITED | 163.96 Million INR | 82.602% |
| Paramount Cosmetics (India) Limited | 205.72 Million INR | 86.133% |
| Pee Cee Cosma Sope Limited | 80.17 Million INR | 64.42% |
| Procter & Gamble Hygiene and Health Care Limited | 10.83 Billion INR | 99.737% |